| 000 | 01746 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515011045.0 | ||
| 264 | 0 | _c20060316 | |
| 008 | 200603s 0 0 pol d | ||
| 022 | _a0423-104X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTałalaj, Marek | |
| 245 | 0 | 0 |
_a[Administration of 1 alpha-OH vitamin D3 and calcium prevents bone mass loss in patients with advanced prostatic carcinoma after orchidectomy treated with complete androgenic blockade]. _h[electronic resource] |
| 260 |
_bEndokrynologia Polska _c |
||
| 300 |
_a225-32 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Regeneration _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xblood |
| 650 | 0 | 4 |
_aCalcium, Dietary _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFlutamide _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxycholecalciferols _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrchiectomy _xadverse effects |
| 650 | 0 | 4 |
_aOsteomalacia _xetiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xtherapy |
| 700 | 1 | _aKapitan-Malinowska, Barbara | |
| 700 | 1 | _aDebski, Krzysztof | |
| 700 | 1 | _aNowakowski, Robert | |
| 700 | 1 | _aMarcinowska-Suchowierska, Ewa | |
| 700 | 1 | _aWiteska, Alojzy | |
| 773 | 0 |
_tEndokrynologia Polska _gvol. 56 _gno. 3 _gp. 225-32 |
|
| 999 |
_c15971286 _d15971286 |
||